71 related articles for article (PubMed ID: 23961491)
21. [The efficacy and safety of pioglitazone hydrochloride in combination with sulphonylureas and metfomin in the treatment of type 2 diabetes mellitus a 12-week randomized multi-centres placebo-controlled parallel study].
Pan C; Gao Y; Gao X; Li G; Luo B; Shi H; Tian H; Jia P; Lin H; Xing X; Zhao Y; Zhou L
Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):388-92. PubMed ID: 12137601
[TBL] [Abstract][Full Text] [Related]
22. Clinical experience with insulin detemir in patients with type 2 diabetes from the near East countries.
Echtay A; Tsur A; Hasan MI; Abu-Hijleh MO; Al Khatib N; Andari E; Atallah P; Qureshi S; Zafar J; Sandalci L; Ademogulları A; Haddad J; Dagan B
Diabetes Ther; 2013 Dec; 4(2):399-408. PubMed ID: 24108581
[TBL] [Abstract][Full Text] [Related]
23. Pioglitazone and the risk of bladder cancer: An Indian retrospective cohort study.
Gupta S; Gupta K; Ravi R; Mehta V; Banerjee S; Joshi S; Saboo B
Indian J Endocrinol Metab; 2015; 19(5):639-43. PubMed ID: 26425474
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Vildagliptin and Pioglitazone in Korean Patients with Type 2 Diabetes Inadequately Controlled with Metformin.
Kim JH; Kim SS; Baek HS; Lee IK; Chung DJ; Sohn HS; Bae HY; Kim MK; Park JH; Choi YS; Kim YI; Hahm JR; Lee CW; Jo SR; Park MK; Lee KJ; Kim IJ
Diabetes Metab J; 2016 Jun; 40(3):230-9. PubMed ID: 27098505
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of pioglitazone/metformin fixed-dose combination therapy compared with pioglitazone and metformin monotherapy in treating patients with T2DM.
Perez A; Zhao Z; Jacks R; Spanheimer R
Curr Med Res Opin; 2009 Dec; 25(12):2915-23. PubMed ID: 19827910
[TBL] [Abstract][Full Text] [Related]
26. Patients with type 2 diabetes inadequately controlled on premixed insulin: effect of initiating insulin glargine plus oral antidiabetic agents on glycaemic control in daily practice.
Hammer H; Klinge A
Int J Clin Pract; 2007 Dec; 61(12):2009-18. PubMed ID: 17997807
[TBL] [Abstract][Full Text] [Related]
27. Assessment of the efficacy and tolerability of a fixed dose combination of atorvastatin 10 mg + metformin SR 500 mg in diabetic dyslipidaemia in adult Indian patients.
Balasubramanian R; Varadharajan S; Kathale A; Nagraj LM; Periyandavar I; Nayak UP; Sharma A; Bolmall C; Baliga VP
J Indian Med Assoc; 2008 Jul; 106(7):464-7. PubMed ID: 18975505
[TBL] [Abstract][Full Text] [Related]
28. Short Term Efficacy and Safety of Insulin Glargine in Type 2 Diabetes Inadequately Controlled with Single or Two Oral Agents: A Prospective, Open Label Study.
Aggarwal A; Wadhwa R
J Clin Diagn Res; 2017 Jul; 11(7):OC21-OC24. PubMed ID: 28892956
[TBL] [Abstract][Full Text] [Related]
29. Improved glycemic control and lipid profile in a randomized study of pioglitazone compared with acarbose in patients with type 2 diabetes mellitus.
Göke B;
Treat Endocrinol; 2002; 1(5):329-36. PubMed ID: 15832486
[TBL] [Abstract][Full Text] [Related]
30. Effects of one year treatment of vildagliptin added to pioglitazone or glimepiride in poorly controlled type 2 diabetic patients.
Derosa G; Maffioli P; Ferrari I; Mereu R; Ragonesi PD; Querci F; Franzetti IG; Gadaleta G; Ciccarelli L; Piccinni MN; D'Angelo A; Salvadeo SA
Horm Metab Res; 2010 Aug; 42(9):663-9. PubMed ID: 20560108
[TBL] [Abstract][Full Text] [Related]
31. Pioglitazone metabolic effect in metformin-intolerant obese patients treated with sibutramine.
Derosa G; Mereu R; Salvadeo SA; D'Angelo A; Ciccarelli L; Piccinni MN; Ferrari I; Gravina A; Maffioli P; Cicero AF
Intern Med; 2009; 48(5):265-71. PubMed ID: 19252346
[TBL] [Abstract][Full Text] [Related]
32. A Real-World Observational Study Evaluating the Probability of Glycemic Control with Basal Insulin or Glucagon-Like Peptide-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes.
Baxter M; Morimoto Y; Tamiwa M; Hattori M; Peng XV; Lubwama R; Maegawa H
Diabetes Ther; 2020 Jul; 11(7):1481-1496. PubMed ID: 32445125
[TBL] [Abstract][Full Text] [Related]
33. A Multicenter, Prospective, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Saroglitazar 2 and 4 mg Compared to Pioglitazone 45 mg in Diabetic Dyslipidemia (PRESS V).
Pai V; Paneerselvam A; Mukhopadhyay S; Bhansali A; Kamath D; Shankar V; Gambhire D; Jani RH; Joshi S; Patel P
J Diabetes Sci Technol; 2014 Jan; 8(1):132-141. PubMed ID: 24876549
[TBL] [Abstract][Full Text] [Related]
34. Addition of Basal Insulin to Oral Antidiabetic Agents in Patients with Inadequately Controlled Type 2 Diabetes Leads to Improved HbA1c Levels: Metabolic Control, Frequency of Hypoglycemia, and Insulin Titration Analysis as Results of a Prospective Observational Study (BALI Study).
Brož J; Janíčková Ždárská D; Štěpánová R; Kvapil M
Diabetes Ther; 2019 Apr; 10(2):663-672. PubMed ID: 30788806
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double-blind, randomized trial.
Schernthaner G; Matthews DR; Charbonnel B; Hanefeld M; Brunetti P;
J Clin Endocrinol Metab; 2004 Dec; 89(12):6068-76. PubMed ID: 15579760
[TBL] [Abstract][Full Text] [Related]
36. Real-World Assessment of Personalized Approach With Voglibose Fixed-Dose Combination in Type 2 Diabetes Mellitus.
Parmar N; Gupta AK; Jhaveri K; A B; Chhaya G; Kansara S; Nair R; Korukonda KR
Cureus; 2024 Apr; 16(4):e57494. PubMed ID: 38707131
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the Effectiveness and Safety of Vildagliptin Add-On to Metformin Versus Other Oral Dual Antidiabetes Agents in Patients with Type 2 Diabetes: The China Prospective Diabetes Study.
Zang L; Han Y; Chen L; Hu D; Jin H; Yang N; Shi X; Liang L; Liu M; Fan H; Li Q; Mu Y
Diabetes Ther; 2019 Aug; 10(4):1391-1405. PubMed ID: 31222594
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of pioglitazone on glycemic control and carotid intima-media thickness in type 2 diabetes patients with inadequate insulin therapy.
Yasunari E; Takeno K; Funayama H; Tomioka S; Tamaki M; Fujitani Y; Kawamori R; Watada H; Hirose T
J Diabetes Investig; 2011 Jan; 2(1):56-62. PubMed ID: 24843462
[TBL] [Abstract][Full Text] [Related]
39. Current status of management, control, complications and psychosocial aspects of patients with diabetes in India: Results from the DiabCare India 2011 Study.
Mohan V; Shah SN; Joshi SR; Seshiah V; Sahay BK; Banerjee S; Wangnoo SK; Kumar A; Kalra S; Unnikrishnan AG; Sharma SK; Rao PV; Akhtar S; Shetty RV; Das AK;
Indian J Endocrinol Metab; 2014 May; 18(3):370-8. PubMed ID: 24944934
[TBL] [Abstract][Full Text] [Related]
40. A retrospective study on finding correlation of pioglitazone and incidences of bladder cancer in the Indian population.
Balaji V; Seshiah V; Ashtalakshmi G; Ramanan SG; Janarthinakani M
Indian J Endocrinol Metab; 2014 May; 18(3):425-7. PubMed ID: 24944944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
